Technical Analysis for TTOO - T2 Biosystems, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| C | 5.14 | 1.58% | 0.08 |
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Up | Up | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Shooting Star Candlestick | Bearish | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| MACD Bearish Signal Line Cross | Bearish | 1.58% | |
| Narrow Range Bar | Range Contraction | 1.58% | |
| Wide Bands | Range Expansion | 1.58% | |
| NR7 | Range Contraction | 0.98% | |
| Narrow Range Bar | Range Contraction | 0.98% | |
| Inside Day | Range Contraction | 0.98% | |
| Wide Bands | Range Expansion | 0.98% | |
| Wide Bands | Range Expansion | 1.58% |
| Alert | Time |
|---|---|
| 10 DMA Resistance | 2 days ago |
| Rose Above Previous Day's High | 2 days ago |
| Rose Above 10 DMA | 2 days ago |
| Up 5% | 2 days ago |
| 60 Minute Opening Range Breakout | 2 days ago |
Get this analysis on your stocks daily!
- Earnings date: 05/06/2024
T2 Biosystems, Inc. Description
T2 Biosystems, Inc., an in vitro diagnostics company, develops diagnostic products based on its proprietary platform. Its T2 Magnetic Resonance platform enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, and urine. The company offers T2Dx, a bench-top instrument, which has completed a pivotal clinical trial for performing diagnostic tests in sepsis and other applications; and T2Stat, an integrated instrument for hemostasis applications. It is also developing T2Candida panel that has completed a pivotal clinical trial for identifying pathogens associated with sepsis; T2HemoStat panel, which includes a set of hemostasis measurements, including platelet function, clotting time, and clot degradation; and T2Bacteria, a multiplex diagnostic panel that detects the bacterial pathogens associated with sepsis. T2 Biosystems, Inc. was founded in 2006 and is headquartered in Lexington, Massachusetts.
Classification
Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Medicine Cell Biology Biomarkers In Vitro Diagnostic Products Diagnostic Tests Magnetic Resonance Blood Plasma Blood Coagulation Intensive Care Medicine In Vitro Diagnostics Pivotal Platelet Coagulation System Hemostasis Sepsis Whole Blood
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 10.46 |
| 52 Week Low | 0.054 |
| Average Volume | 368,124 |
| 200-Day Moving Average | 3.64 |
| 50-Day Moving Average | 3.67 |
| 20-Day Moving Average | 4.70 |
| 10-Day Moving Average | 5.32 |
| Average True Range | 0.58 |
| RSI (14) | 58.51 |
| ADX | 46.25 |
| +DI | 31.59 |
| -DI | 11.24 |
| Chandelier Exit (Long, 3 ATRs) | 4.81 |
| Chandelier Exit (Short, 3 ATRs) | 4.71 |
| Upper Bollinger Bands | 6.60 |
| Lower Bollinger Band | 2.79 |
| Percent B (%b) | 0.62 |
| BandWidth | 81.19 |
| MACD Line | 0.46 |
| MACD Signal Line | 0.49 |
| MACD Histogram | -0.0344 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 5.74 | ||||
| Resistance 3 (R3) | 5.77 | 5.59 | 5.64 | ||
| Resistance 2 (R2) | 5.59 | 5.44 | 5.58 | 5.61 | |
| Resistance 1 (R1) | 5.36 | 5.34 | 5.48 | 5.34 | 5.58 |
| Pivot Point | 5.19 | 5.19 | 5.24 | 5.18 | 5.19 |
| Support 1 (S1) | 4.96 | 5.03 | 5.08 | 4.94 | 4.70 |
| Support 2 (S2) | 4.79 | 4.94 | 4.77 | 4.67 | |
| Support 3 (S3) | 4.56 | 4.79 | 4.64 | ||
| Support 4 (S4) | 4.54 |
